Prostate cancer: Simple urine test may help with early detection
Scientists are working on developing a urine test to detect prostate cancer.Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages.
Now, researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of prostate cancer.
The study combines artificial intelligence with detailed genetic analysis and could potentially offer an alternative to current PSA testing.
Prostate cancer is one of the most frequently diagnosed cancers in men yet is often highly treatable when detected early. It originates in the prostate gland, located between the bladder and the penis.
While the exact cause remains unknown, the likelihood of developing the disease increases with age.
One reason early detection is challenging is the absence of reliable biomarkers that can accurately indicate the onset of the disease.
This new research, published in the journal Cancer Research, suggests that early-stage prostate cancer can be detected using a simple urine test.
Researchers created digital models of prostate cancer by analysing mRNA activity across all human genes in thousands of individual tumour cells, each classified by cancer grade and location.
They used artificial intelligence to examine these models and identify proteins that could act as potential biomarkers.
These biomarkers were then tested in blood, prostate tissue and urine samples from nearly 2,000 patients.
First author Martin Smelik explained the key findings to Medical News Today .
'The key finding of this article is that prostate cancer can be effectively identified by analyzing the expression of candidate biomarkers in urine,' Smelik explained.
'This approach [via a urine sample] outperforms the current blood tests based on PSA but at the same time keeps the advantages of being non-invasive, painless, and relatively cheap.'
— Martin Smelik
A specific set of urine-based biomarkers showed strong potential in detecting both the presence and severity of prostate cancer with greater accuracy than PSA, the current standard blood-based marker.
A PSA test is a simple blood test that checks the level of a protein called prostate-specific antigen, which is made by the prostate.
High levels of PSA can be a sign of prostate cancer, but they can also be caused by other conditions like an enlarged or inflamed prostate.
Plans are now in place to conduct large-scale clinical trials to further validate the findings.
In addition, discussions are underway to include the novel biomarkers in a UK-wide prostate cancer study to speed up testing and implementation.
'This publication brings hope for more efficient screening programs within next few years, which might ultimately help to prevent and treat prostate cancer. While this study was focused specifically on prostate cancer, we believe that some of the methods could be generalized to other cancers as well, which we would like to try in our future studies.'
— Martin Smelik
These improvements may also help reduce the number of unnecessary biopsies in men who do not have the disease.
Milan Sheth, MD, quadruple board certified in internal medicine, hematology, oncology, and palliative care, at MemorialCare Todd Cancer Institute at Long Beach Medical Center in Long Beach, CA, who was not involved in the study, said that this is an impressive study utilising artificial intelligence to find alternative methods and bio markers for diagnosing prostate cancer.
'Early diagnosis and treatment are critical for preventing such complications. However, current methods for diagnosing prostate cancer utilize uncomfortable, and invasive approaches that can only be performed by a urologist.'
— Milan Sheth
'The findings from the current paper showed that specific biomarkers which are dynamic and more sensitive than PSA can actually be found in the urine,' Sheth told MNT . 'Remarkably, the urinary bio markers demonstrated exceptional diagnostic precision, and we're capable of distinguishing not only cancerous from non-cancer states but also indicating disease severity.'
'This discovery could potentially change the ways in which prostate cancer is not only diagnosed but can also be used as a more accurate screening mechanism, which we desperately need. And all this simply through a urine test,' Sheth said.
Ramkishen Narayanan, MD, board certified urologist and urologic oncologist and Director of the Center for Urologic Health at The Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center in Burbank, CA, agreed, saying that 'this paper presents an exciting area of research.'
'With respect to prostate cancer, serum PSA has remained the only reliable 'biomarker' for nearly 50 years at this point. We are long overdue for additional biomarkers that can both detect prostate cancer and monitor prostate cancer progression.'
— Ramkishen Narayanan
Narayanan pointed out that 'the study authors make note that urine may be an excellent modality for finding a reliable biomarker due to the 'local fluids' near cancer concept.'
'Urine is intimately associated with the prostate and a urinary biomarker for prostate cancer is an ongoing area of research worldwide,' he said.
'Spatial transcriptomics is unfortunately very expensive; therefore, a globally collaborative approach (such as the cancer genome atlas program) would be the most beneficial to the public,' Narayanan added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
2 hours ago
- The Guardian
Sight of someone potentially infectious causes immune response, research suggests
Whether it's the person brandishing a tissue on the train or the child with the telltale signs of chickenpox, the threat of an infection can be enough for us to beat a retreat. Now researchers using virtual reality avatars have shown that the mere sight of a potentially contagious person is enough to mobilise our immune system too. 'Although surprising, our finding that immune responses can be triggered by simulated infections presented in VR is consistent with the principle of the smoke detector in biological systems,' the authors said, adding the behavioural system that helps us avoid catching diseases is 'exquisitely sensitive' to cues that may suggest someone is sick. Writing in the journal Nature Neuroscience, the researchers reported how they fitted 248 healthy people with VR headsets and carried out five experiments, each involving a minimum of 32 participants. In each experiment, participants initially watched three faces of the same sex as themselves repeatedly loom towards them, bearing a neutral expression. Participants were then split into groups and shown the same three faces multiple times, either with a neutral expression or signs of viral infections such as skin rashes. In some experiments, an additional subset of participants were shown the faces displaying an expression of fear. In one experiment, participants were asked to press a button as fast as possible after receiving a mild touch to their face while an avatar was shown. The team found that when the avatars showed signs of sickness, participants pressed the button when the faces appeared further away than for faces showing a neutral or fearful expression. Results from EEG tests to investigate the electrical activity of the brain tallied with these findings. As expected, as avatars loomed closer, the brain system that represents the space closely surrounding our body became activated. However, this activation differed when the avatars showed signs of infection compared with neutral expressions, even when they appeared far away. These differences, the team add, were localised in areas of the brain involved in detecting and filtering threats. The team found that functional MRI (fMRI) brain scans supported these results, further revealing that when infectious avatars were shown there was a greater connection between this threat-detection network and part of the brain called the hypothalamus, which acts as a key regulation centre for the body. The team also found differences in participants' blood when they were shown the infectious avatars compared with neutral or fearful faces. '[In terms of cells], we saw mainly that there is an activation of an immune cell family called the innate lymphoid cells (ILCs)that [are] early responders in immunity to basically alarm other immune cells,' said Prof Camilla Jandus of the University of Geneva and an author of the study. The team added that they found a similar activation of ILCs when they examined the blood of individuals who had received an influenza vaccine but had not been exposed to the VR setup. Dr Esther Diekhof of the University of Hamburg, who was not involved in the work, said the study chimed with previous research, including that of her own team. 'The study provides yet another good example for the existence of a mechanism that responds to potential contagion threats even before the immune system has come into contact with pathogens,' she said. But Prof Benedict Seddon, of University College London, said questions remained, including whether the observed responses help the immune system actually fight an infection. 'When we get infected, by Sars-CoV for instance, it can take a day or two for the infection to establish and for the immune system to become aware of it and respond, a long time after the initial encounter that stimulated this short-lived mobilisation,' he said.
The Independent
2 hours ago
- The Independent
Luka Doncic credits his new physique to nutrition and training
Lakers star Luka Doncic has unveiled a significantly more muscular physique, which he attributes to an intense training and diet regimen during the off-season. His transformation was showcased in a Men's Health cover story, where he discussed his commitment to a gluten-free, low-sugar diet and two daily workouts. Fans have reacted enthusiastically to Doncic's new look, widely dubbing it a 'revenge body' following his trade from the Dallas Mavericks to the Los Angeles Lakers in February. The trade, which saw Anthony Davis move to the Mavericks, reportedly stemmed from concerns within the Mavericks organization about Doncic's weight and conditioning. Despite fan backlash, Mavericks general manager Nico Harrison defended his decision to trade Doncic, stating he had 'no regrets' and that the move was in the team's best interest.
The Independent
3 hours ago
- The Independent
‘God is so good': Deion Sanders opens up about his battle with bladder cancer
Colorado Buffaloes coach Deion Sanders revealed he was diagnosed with an aggressive form of bladder cancer. Sanders underwent surgery to remove his bladder and create a new one, with doctors confirming he is now cured of the disease. He disclosed that he lost 25 pounds during his illness and joked about now needing to use absorbent underwear. The cancer was discovered during a routine CT scan for blood clots, prompting Sanders to encourage others to get regular medical check-ups. Sanders kept his diagnosis secret from his sons, telling them it was a foot issue, to allow them to focus on the NFL draft.
